Argyle Capital Management’s Eastman Chemical EMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $716K | Buy |
11,050
+350
| +3% | +$24.4K | 0.21% | 98 |
|
|
2026
Q2 | $717K | Buy |
10,700
+2,900
| +37% | +$212K | 0.21% | 98 |
|
|
2026
Q1 | $595K | Buy |
7,800
+3,335
| +75% | +$240K | 0.19% | 103 |
|
|
2025
Q4 | $285K | Hold |
4,465
| – | – | 0.1% | 125 |
|
|
2025
Q3 | $282K | Hold |
4,465
| – | – | 0.1% | 122 |
|
|
2025
Q2 | $333K | Buy |
4,465
+1,000
| +29% | +$78.6K | 0.12% | 117 |
|
|
2025
Q1 | $305K | Buy |
3,465
+689
| +25% | +$65.1K | 0.11% | 118 |
|
|
2024
Q4 | $254K | Buy |
2,776
+311
| +13% | +$31.9K | 0.1% | 120 |
|
|
2024
Q3 | $276K | Sell |
2,465
-935
| -28% | -$93.5K | 0.11% | 113 |
|
|
2024
Q2 | $333K | Hold |
3,400
| – | – | 0.14% | 111 |
|
|
2024
Q1 | $341K | Hold |
3,400
| – | – | 0.13% | 104 |
|
|
2023
Q4 | $305K | Hold |
3,400
| – | – | 0.13% | 101 |
|
|
2023
Q3 | $261K | Hold |
3,400
| – | – | 0.1% | 112 |
|
|
2023
Q2 | $285K | Hold |
3,400
| – | – | 0.1% | 110 |
|
|
2023
Q1 | $287K | Hold |
3,400
| – | – | 0.1% | 116 |
|
|
2022
Q4 | $277K | Hold |
3,400
| – | – | 0.1% | 116 |
|
|
2022
Q3 | $242K | Hold |
3,400
| – | – | 0.09% | 118 |
|
|
2022
Q2 | $305K | Hold |
3,400
| – | – | 0.11% | 116 |
|
|
2022
Q1 | $381K | Hold |
3,400
| – | – | 0.12% | 112 |
|
|
2021
Q4 | $411K | Hold |
3,400
| – | – | 0.13% | 110 |
|
|
2021
Q3 | $343K | Hold |
3,400
| – | – | 0.11% | 114 |
|
|
2021
Q2 | $397K | Hold |
3,400
| – | – | 0.13% | 113 |
|
|
2021
Q1 | $374K | Hold |
3,400
| – | – | 0.13% | 114 |
|
|
2020
Q4 | $341K | Hold |
3,400
| – | – | 0.13% | 110 |
|
|
2020
Q3 | $266K | Hold |
3,400
| – | – | 0.11% | 114 |
|
|
2020
Q2 | $237K | Buy |
+3,400
| New | +$214K | 0.1% | 113 |
|
|
2020
Q1 | – | Sell |
-3,400
| Closed | -$269K | – | 125 |
|
|
2019
Q4 | $269K | Hold |
3,400
| – | – | 0.1% | 118 |
|
|
2019
Q3 | $251K | Hold |
3,400
| – | – | 0.09% | 117 |
|
|
2019
Q2 | $265K | Hold |
3,400
| – | – | 0.1% | 116 |
|
|
2019
Q1 | $258K | Hold |
3,400
| – | – | 0.1% | 113 |
|
|
2018
Q4 | $249K | Hold |
3,400
| – | – | 0.11% | 109 |
|
|
2018
Q3 | $325K | Hold |
3,400
| – | – | 0.12% | 107 |
|
|
2018
Q2 | $340K | Hold |
3,400
| – | – | 0.13% | 106 |
|
|
2018
Q1 | $359K | Hold |
3,400
| – | – | 0.14% | 107 |
|
|
2017
Q4 | $315K | Hold |
3,400
| – | – | 0.12% | 111 |
|
|
2017
Q3 | $308K | Hold |
3,400
| – | – | 0.12% | 110 |
|
|
2017
Q2 | $286K | Hold |
3,400
| – | – | 0.12% | 111 |
|
|
2017
Q1 | $275K | Hold |
3,400
| – | – | 0.11% | 112 |
|
|
2016
Q4 | $256K | Hold |
3,400
| – | – | 0.11% | 113 |
|
|
2016
Q3 | $230K | Hold |
3,400
| – | – | 0.1% | 112 |
|
|
2016
Q2 | $231K | Hold |
3,400
| – | – | 0.1% | 110 |
|
|
2016
Q1 | $246K | Hold |
3,400
| – | – | 0.11% | 108 |
|
|
2015
Q4 | $230K | Hold |
3,400
| – | – | 0.11% | 110 |
|
|
2015
Q3 | $220K | Buy |
+3,400
| New | +$251K | 0.11% | 110 |
|
Other funds holding EMN
Argyle Capital Management's EMN Position: Q3 2026 in Review
Argyle Capital Management increased its Eastman Chemical (EMN) stake by 3.3% in Q3 2026, buying an estimated $24.4K and bringing the position to 11,050 shares worth $716K. The position accounts for 0.21% of the portfolio, ranked #98.
Argyle Capital Management first reported a position in EMN in Q3 2015 and has held it in 44 quarters since. The position peaked at $717K in Q2 2026. 228 funds tracked by Wall St. Rank hold EMN as of Q3 2026.
- Argyle Capital Management held 11,050 shares of Eastman Chemical worth $716K as of Q3 2026.
- Argyle Capital Management bought 350 Eastman Chemical shares in Q3 2026, an estimated $24.4K.
- Eastman Chemical made up 0.21% of Argyle Capital Management's portfolio in Q3 2026, its #98 holding.
- Argyle Capital Management first reported a position in Eastman Chemical in Q3 2015 and has held it in 44 quarters since.
- Argyle Capital Management's Eastman Chemical position peaked at $717K in Q2 2026.
- 228 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2026.
Based on Argyle Capital Management's 13F filing for Q3 2026, filed 28 Oct 2026.